Arizona HB4036 prohibits the sale of compounded drugs unless they meet specific safety and quality standards.
Arizona HB4036 amends state law to ensure the safety and integrity of compounded medications. It prohibits the sale, transfer, or distribution of compounded drugs unless the seller provides verification that the bulk drug substances used are pharmaceutical grade and meet sourcing requirements. Sellers must also document quality control testing and ensure compliance with federal standards. The Arizona State Board of Pharmacy is authorized to inspect entities involved in compounding drugs to enforce these provisions. Violations may result in civil penalties and license suspensions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.